Good catch, for lung cancer that really does look like the case. The others look like Kevetrin starts losing the battle after awhile -- especially Pancreatic -- but this is before the dose is optimized and the optimal dosing SCHEDULE hasn't been established either.

It is absolutely stunning. Makes me feel good about my new stock purchased today -- though I 'm chagrined that I was able to buy so cheaply.